dapirolizumab pegol: Clinical Trials

3 trials of dapirolizumab pegol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 enrolling by invitation, 1 recruiting. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Completed 1, Enrolling by invitation 1, Recruiting 1

Follow dapirolizumab pegol: new trials by email Literature Review of dapirolizumab pegol trials Research Report on dapirolizumab pegol

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
DZP, Placebo - Systemic Lupus Erythematosus
Phase 3RecruitingUCB Biopharma SRL4502024-11-212026-11-02
A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus
Dapirolizumab pegol - Systemic Lupus Erythematosus
Phase 3Enrolling by invitationUCB Biopharma SRL7602021-07-272026-11-13
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
DZP, Placebo - Systemic Lupus Erythematosus
Phase 3CompletedUCB Biopharma SRL3212020-08-122025-05-04

Conditions studied

Lupus Erythematosus, Systemic (3)

Sponsors

UCB Biopharma SRL (3)

Countries

Argentina (3)  ·  Belgium (3)  ·  Canada (3)  ·  Chile (3)  ·  Germany (3)  ·  Greece (3)  ·  Italy (3)  ·  Mexico (3)  ·  Peru (3)  ·  Poland (3)  ·  Serbia (3)  ·  South Korea (3)  ·  Spain (3)  ·  Taiwan (3)  ·  United States (3)

Results publications

PMID 42214397

NIH funding

2019 (3), 2023 (2)